A study on appetite loss in chronic hepatitis C patients terated with telaprevir, ribavirin and PEG-IFN.

A study on appetite loss in chronic hepatitis C patients terated with telaprevir, ribavirin and PEG-IFN. - A study on appetite loss in chronic hepatitis C patients during IFN treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009057

Enrollment

Registered

2012-10-26

Start date

2012-10-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis C

Interventions

blood collection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic hepatitis C patients treated with telaprevir, ribavirin and PEGIFN

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
serum ghrelin level	—

Countries

Japan

Contacts

Public ContactSumiko Nagoshi

Saitama Medical University, Saitama Medical Center Dept. of Gastroenterology and Hepatology

snagoshi@saitama-med.ac.jp049-228-3564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026